Glassy cell variant of human papillomavirus associated poorly differentiated adenosquamous carcinoma with concurrent adenocarcinoma in situ: a rare case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20254306Keywords:
Glassy cell carcinoma, CervicitisAbstract
Glassy cell carcinoma (GCC) of the uterine cervix is a rare neoplasm, first described by Gluksman and Cherry in 1956. It is a poorly differentiated adenosquamous carcinoma, comprising about 1-2% of all cervical cancers. It is considered to originate from the subcylindrical reserve cells of the cervix and has been associated with human papillomavirus (HPV). Histologically glassy cell carcinoma is composed of nests of large cells with ground glass nucleoli. Nuclear pleomorphism and tumour giant cells are frequently seen. Mitotic activity is brisk. Infiltration by eosinophils and plasma cells with admixture of lymphocytes is a characteristic feature. we report a case of 44-year female who presented with per vaginal bleeding and white discharge which was diagnosed clinically as cervicitis. On pap smear it was reported as NILM- inflammation probably because of its rich inflammatory stroma. Ultrasonography (USG) abdomen and pelvis done which showed mild bulky cervix with changes of cervicitis. We performed P16 which was diffuse block like positivity along with p63 and CK 7 which confirms the adenosquamous presentation and highlights adenocarcinoma in situ arising from endocervical glands. Cervical GCC was recognized as a rare histological entity associated with poor prognosis since the report from Cherry and Glucksmann. We reported a rare case of GCC of cervix variant of poorly differentiated adenosquamous carcinoma associated with HPV and concurrent adenocarcinoma in situ, confirmed on immunohistochemistry.
References
Cherry CP, Glucksmann A. Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix. Cancer. 1956;9:971-9.
Gray HJ, Garcia R, Tamimi HK, Koh WJ, Goff BA, Greer BE, et al. Glassy cell carcinoma of the cervix revisited. Gynecol Oncol. 2002;85(2):274-7.
Guitarte C, Alagkiozidis I, Mize B, Stevens E, Salame G, Lee YC. Glassy cell carcinoma of the cervix: a systematic review and meta-analysis. Gynecol Oncol. 2014;133(2):186-91.
Littman P, Clement PB, Henriksen B, Wang CC, Robboy SJ, Taft PD, et al. Glassy cell carcinoma of the cervix. Cancer. 1976;37(5):2238-46.
Höhn AK, Brambs CE, Hiller GGR, May D, Schmoeckel E, Horn LC. 2020 WHO Classification of Female Genital Tumors. Geburtshilfe Frauenheilkd. 2021;81(10):1145-53.
Wang Q, Hu Y, He Y, Wang T, Ghimire P. Glassy cell carcinoma of cervix: an analysis for 20 cases and literatures review. Transl Cancer Res. 2020;9(4):2357-62.
Kosiniska-Kaczynska K, Mazanowska N, Bomba-Opon D, Horosz E, Marczewska M, Wielgos M. Glassy cell carcinoma of the cervix-a case report with review of the literature”. Ginekol Pol. 2011;82:936.
Habara K, Nishikori A, Kiyama J, Nakashima M, Koda M, Sasaki K, et al. A case of coexistent poorly differentiated adenosquamous carcinoma (glassy cell carcinoma), usual-type adenocarcinoma, and squamous cell carcinoma in situ of the cervix. Med Mol Morphol. 2023;56(3):217-24.
Inoue T, Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation. Cancer, 1984;54:1714-9.
Habib N, Dennis T, Centini G, Bresson L, Narducci F, Leblanc E. Glassy cell carcinoma: is surgical treatment with preservation of the uterus a therapeutic option. Eur J Gynaecol Oncol. 2020;41(1):121-5.